Drug Index

MYCOPHENOLATE SODIUM

Generic: MYCOPHENOLATE SODIUM

Review priority: STANDARD Marketing status: Prescription

Route: ORAL
Class: General Medications
Safety profile: routine
Latest regulatory update: 14 Jan 2026, 12:00 am (UTC)

Structured Monograph

Approval overview MYCOPHENOLATE SODIUM is listed in Drugs@FDA under application 218603 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MYCOPHENOLATE SODIUM Form and strength TABLET, DELAYED RELEASE;ORAL - EQ 360MG BASE Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2026-01-14 00:00:00. Submission type: SUPPL.